GGrantIndex
Sort

64,565 grants matching drug discovery

University of New Mexico Center for Metals in Biology and Medicine

$2,521,061
Matthew J Campen · University Of New Mexico Health Scis Ctr · P20 · FY2020 · GM

Cancer Center Support Grant

$2,520,000
Steven Terry Rosen · Beckman Research Institute/City Of Hope · P30 · FY2016 · CA

DATA SCIENCE RESEARCH

$2,519,215
Peipei Ping · University Of California Los Angeles · U54 · FY2016 · GM

Development of on-chip ultra high-throughput whole-animal assay technologies

$2,517,500
Mehmet Fatih Yanik · Massachusetts Institute Of Technology · DP2 · FY2007 · OD

Exploiting membrane targets to overcome antibiotic resistance

$2,515,155
Suzanne L. Walker · Harvard Medical School · U19 · FY2023 · AI

Exploiting membrane targets to overcome antibiotic resistance

$2,515,155
Suzanne L. Walker · Harvard Medical School · U19 · FY2025 · AI

Exploiting membrane targets to overcome antibiotic resistance

$2,515,155
Suzanne L. Walker · Harvard Medical School · U19 · FY2024 · AI

Discovery metabolite profiling of the prolyl peptidases

$2,514,500
Alan Saghatelian · Harvard University · DP2 · FY2007 · OD

Immunologic And Virologic Approaches To HIV-1 Therapeutics

$2,513,865
Richard Davey · Niaid Extramural Activities · Z01 · FY2007 · AI

Defining tumor cell and host adaptations in cancer progression

$2,512,500
Mandar Deepak Muzumdar · Yale University · DP2 · FY2019 · CA

The Pediatric Brain Tumor Consortium (PBTC)

$2,510,122
James M Boyett · St. Jude Children'S Research Hospital · U01 · FY2008 · CA

Collaboration on preclinical autism cellular assays, biosignatures, and network analyses (Copacabana)

$2,507,332
Eugene Wei-Ming Yeo · University Of California, San Diego · U19 · FY2016 · MH

Brain Tumor Therapeutic Efficacy of Quantitative MR

$2,504,121
Brian D. Ross · University Of Michigan At Ann Arbor · P01 · FY2009 · CA

Metabolic factors that control the spectrum of human tuberculosis

$2,504,101
David Branch Moody · Brigham And Women'S Hospital · U19 · FY2021 · AI

Collaboration on preclinical autism cellular assays, biosignatures, and network analyses (Copacabana)

$2,503,148
Eugene Wei-Ming Yeo · University Of California, San Diego · U19 · FY2017 · MH

Positioning Mason's Regional Biocontainment Laboratory for Effective Pandemic Preparedness

$2,501,503
Farhang Alem · George Mason University · UC7 · FY2025 · AI

Analytical Chemistry

$2,500,589
Christopher Arthur Leclair · National Center For Advancing Translational Sciences · ZIC · FY2023 · TR

An integrated translational approach to overcome drug resistance

$2,500,407
Ryan Bruce Corcoran · Massachusetts General Hospital · U54 · FY2017 · CA

Data Coordination and Integration Center for LINCS-BD2K

$2,500,000
Avi Ma'ayan · Icahn School Of Medicine At Mount Sinai · U54 · FY2014 · HL

Center for Identification and Study of Individuals with Atypical Diabetes Mellitus

$2,500,000
Louis H. Philipson · University Of Chicago · U54 · FY2025 · DK

Case GI SPORE

$2,500,000
Sanford D Markowitz · Case Western Reserve University · P50 · FY2018 · CA

SMARTCORE Technology: Using AI and Patient Tissue to Identify Potential Cancer Therapies for Ultra-rare Cancers

$2,500,000
Taran Singh Gujral · Fred Hutchinson Cancer Center · U01 · FY2023 · FD

SPORE in Breast Cancer

$2,500,000
Vanderbilt University · P50 · FY2003 · CA

NCRM Pilot Grant Funding

$2,500,000
Mahendra Rao · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2012 · AR

RARE and Atypical Diabetes Network(RADIANT)

$2,500,000
Ashok Balasubramanyam · Baylor College Of Medicine · U54 · FY2025 · DK